Prostate Cancer Clinical Trials Consortium

This study tests whether the drug talazoparib, given alone or with enzalutamide, can slow cancer growth in men with a specific type of advanced prostate cancer (metastatic castration-resistant) that has certain gene mutations (HRR) and has already progressed after treatment with …

This study is a large international registry that will follow at least 5,000 men with advanced prostate cancer from 15 countries. Researchers will collect detailed information on treatments, side effects, quality of life, and blood samples over five years. The goal is to understa…